|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date05 Jan 2024 |
100 Clinical Results associated with Lnhc, Inc.
0 Patents (Medical) associated with Lnhc, Inc.
100 Deals associated with Lnhc, Inc.
100 Translational Medicine associated with Lnhc, Inc.